Description

Thymic peptide used as an immunomodulator

Thymosin Alpha 1 is a well-studied immunomodulatory peptide recognized for its ability to strengthen immune defenses, regulate immune activity, and enhance the body’s response to pathogens. Plays a vital role in activating T-cell function and boosting immune system resilience. Has also been shown to help balance immune responses, reduce inflammation, and support recovery from infections. Especially valuable in studies centered on immune regulation and host defense mechanisms.

References

  1. Ancell CD, Phipps J, Young L. Thymosin alpha-1. Am J Health Syst Pharm. 2001;58(10):879-885. PMID: 11381492 | DOI: 10.1093/ajhp/58.10.886
  2. Goldstein AL. Clinical applications of thymosin alpha-1. Cancer Invest. 1994;12(5):545-547. PMID: 7922712 | DOI: 10.3109/07357909409021415
  3. Dinetz E, Lee E. Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1 in Human Clinical Trials. Altern Ther Health Med. 2024;30(1):6-12. PMID: 38308608

Certificate of Analysis

Original laboratory report for Thymosin Alpha-1. Product and labeled strength matched. Vial lot/current-stock association has not been confirmed. Refer to the original report for laboratory findings.

Verify this batch

Print or download (PDF)

Serial: COA-1001295-QUTR · Integrity verified